Trial intelligence / Profile preview

Local Analgesia in Recovery After Digestive Tract Surgery

ChiCTR-IPR-17010452Phase 4Recruiting

Sponsor
The Affiliated Hospital of Qingdao University
Start
Feb 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in gastrointestinal cancer and gastrointestinal stromal tumor (GIST) (3 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Anal exhaust time and Pain score. Started Feb 2017; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

gastrointestinal cancergastrointestinal stromal tumor (GIST)

Beyond the preview

Go deeper on ChiCTR-IPR-17010452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17010452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call